11.96
price up icon3.55%   0.41
after-market Dopo l'orario di chiusura: 11.96
loading
Precedente Chiudi:
$11.55
Aprire:
$11.75
Volume 24 ore:
852.87K
Relative Volume:
0.40
Capitalizzazione di mercato:
$1.91B
Reddito:
$61.10M
Utile/perdita netta:
$-138.36M
Rapporto P/E:
-8.8593
EPS:
-1.35
Flusso di cassa netto:
$-90.59M
1 W Prestazione:
+6.31%
1M Prestazione:
+42.89%
6M Prestazione:
+49.87%
1 anno Prestazione:
+48.57%
Intervallo 1D:
Value
$11.74
$11.96
Intervallo di 1 settimana:
Value
$11.23
$11.96
Portata 52W:
Value
$5.80
$11.96

Ocular Therapeutix Inc Stock (OCUL) Company Profile

Name
Nome
Ocular Therapeutix Inc
Name
Telefono
781-357-4000
Name
Indirizzo
15 CROSBY DRIVE, BEDFORD, MA
Name
Dipendente
274
Name
Cinguettio
@OCUTX
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
OCUL's Discussions on Twitter

Confronta OCUL con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OCUL
Ocular Therapeutix Inc
11.96 1.84B 61.10M -138.36M -90.59M -1.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-08 Iniziato William Blair Outperform
2025-03-18 Iniziato RBC Capital Mkts Outperform
2025-03-11 Iniziato Needham Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-06-20 Aggiornamento TD Cowen Hold → Buy
2024-05-31 Ripresa Piper Sandler Overweight
2024-02-09 Iniziato BofA Securities Buy
2023-04-21 Iniziato Robert W. Baird Outperform
2022-08-10 Ripresa Berenberg Buy
2021-08-10 Aggiornamento H.C. Wainwright Neutral → Buy
2020-12-28 Downgrade H.C. Wainwright Buy → Neutral
2020-12-17 Iniziato Berenberg Buy
2020-11-13 Reiterato Raymond James Strong Buy
2020-08-10 Reiterato H.C. Wainwright Buy
2020-03-03 Aggiornamento Raymond James Outperform → Strong Buy
2019-05-21 Downgrade Cowen Outperform → Market Perform
2019-05-21 Reiterato H.C. Wainwright Buy
2019-05-21 Downgrade Raymond James Strong Buy → Outperform
2018-12-03 Reiterato Cantor Fitzgerald Overweight
2018-11-15 Iniziato Raymond James Strong Buy
2018-09-07 Iniziato Piper Jaffray Overweight
2017-10-24 Iniziato Guggenheim Buy
2017-07-26 Iniziato H.C. Wainwright Buy
2017-07-12 Reiterato Cantor Fitzgerald Overweight
2017-06-23 Downgrade Morgan Stanley Overweight → Equal-Weight
2017-02-10 Iniziato Cantor Fitzgerald Overweight
2016-11-15 Reiterato RBC Capital Mkts Outperform
2016-08-11 Iniziato JMP Securities Mkt Outperform
2016-02-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2015-10-23 Downgrade Morgan Stanley Overweight → Equal-Weight
2015-08-13 Iniziato Morgan Stanley Overweight
Mostra tutto

Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie

pulisher
Jul 23, 2025

What drives Ocular Therapeutix Inc. stock priceMassive wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Ocular Therapeutix stock hits 52-week high at $11.78 - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Ocular Therapeutix Inc. stockAccelerated wealth building - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Ocular Therapeutix Inc. Stock Analysis and ForecastRecord-breaking gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Ocular Therapeutix Announces Participation in Upcoming Scientific Conferences Focused on Retina Innovation - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

Ocular Therapeutix Participates in Upcoming Scientific Conferences - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Ocular Therapeutix Unveils Breakthrough Diabetic Retinopathy Treatment Data Across 3 Major Eye Conferences - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Is Ocular Therapeutix Inc. a good long term investmentRemarkably fast returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

(OCUL) Trading Report - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

FMR LLC's Strategic Acquisition of Ocular Therapeutix Shares: A Financial Analysis - AInvest

Jul 19, 2025
pulisher
Jul 09, 2025

Ocular Therapeutix(OCUL) Soars 8.47% on Pipeline Progress - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Institutional investors control 65% of Ocular Therapeutix, Inc. (NASDAQ:OCUL) and were rewarded last week after stock increased 3.7% - simplywall.st

Jul 07, 2025
pulisher
Jun 30, 2025

Ocular Therapeutix, Inc.(NasdaqGM: OCUL) dropped from Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Ocular Therapeutix, Inc.(NasdaqGM: OCUL) dropped from Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Selling US$1.1m Of Ocular Therapeutix Stock Rewarded Insiders - 富途牛牛

Jun 29, 2025
pulisher
Jun 27, 2025

Ocular Therapeutix™ Unveils New Corporate Branding, Reflecting its Transformation to a Retina-Focused Company - The Manila Times

Jun 27, 2025
pulisher
Jun 26, 2025

Ocular Therapeutix Launches New Corporate Branding to Enhance Retina-Focused Mission - Nasdaq

Jun 26, 2025
pulisher
Jun 25, 2025

Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last? - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Pre-market Movers: NKTR, INM, IBIO, IBO... - RTTNews

Jun 24, 2025
pulisher
Jun 23, 2025

OCUL SEC FilingsOcular Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 23, 2025
pulisher
Jun 19, 2025

Trend Tracker for (OCUL) - news.stocktradersdaily.com

Jun 19, 2025
pulisher
Jun 18, 2025

Ocular Therapeutix to present at Clinical Trials at the Summit 2025 - Ophthalmology Times

Jun 18, 2025
pulisher
Jun 17, 2025

Ocular Therapeutix (NASDAQ:OCUL) shareholders have earned a 33% CAGR over the last three years - Yahoo Finance

Jun 17, 2025
pulisher
Jun 16, 2025

Ocular's Make-Or-Break Moment: Axpaxli Data Looms For Wet AMD Market (Upgrade) (OCUL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 | OCUL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Ocular Therapeutix, Inc. to Present Clinical Trial Results and Insights at Summit 2025 in Las Vegas - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025 - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

Breakthrough Eye Disease Treatment Data: Ocular Therapeutix Reveals Clinical Trial Results at CTS 2025 - Stock Titan

Jun 16, 2025
pulisher
Jun 11, 2025

Ocular Therapeutix Approves Key Amendments at Annual Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Rising Leaders 2025: Namrata Saroj On The Importance Of Authenticity In Ophthalmology - insights.citeline.com

Jun 11, 2025
pulisher
Jun 10, 2025

Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) 26% Jump Shows Its Popularity With Investors - simplywall.st

Jun 10, 2025
pulisher
Jun 06, 2025

Trading (OCUL) With Integrated Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Purchases 40,700 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Buys 45,518 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Nuveen Asset Management LLC Has $3.54 Million Stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

What is HC Wainwright’s Forecast for OCUL Q1 Earnings? - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Ocular gains as Wet AMD trial for lead asset reaches enrollment target - MSN

Jun 01, 2025
pulisher
May 30, 2025

Ocular Therapeutix (NASDAQ:OCUL) Given Buy Rating at HC Wainwright - Defense World

May 30, 2025
pulisher
May 30, 2025

Ocular Therapeutix (OCUL) Maintains "Buy" Rating with $15 Price Target | OCUL Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Takes $3.82 Million Position in Ocular Therapeutix, Inc. (NASDAQ:OCUL) - Defense World

May 30, 2025
pulisher
May 30, 2025

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock Holdings Lessened by Bank of America Corp DE - Defense World

May 30, 2025
pulisher
May 29, 2025

Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews - Benzinga

May 29, 2025
pulisher
May 29, 2025

Ocular Therapeutix (OCUL) Advances with Axpaxli Trial Completion - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Ocular Therapeutix (NASDAQ:OCUL) Has Debt But No Earnings; Should You Worry? - simplywall.st

May 29, 2025

Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):